pharmatechoutlook
4July - 2020TECH OUTLOOKRevolutionizingGenomeEditing with CRISPRIN MY OPINIONCOVER STORYMark Behlke, CSO, Integrated DNA Technologies08LAST WORDRichard Hu, Director of CMC, Arsenal Medical & Ex-Associate Director, Curis [NASDAQ:CRIS]Recent Trends and Developments in Pharmaceutical Industry3012BOSTON ANALYTICALSPEARHEADING INNOVATION IN ADVANCED MICROBIOME TESTINGJames Mich,President
< Page 3 | Page 5 >